Synthesis of δ-Lactones from 5-Oxoalkanals
J . Org. Chem., Vol. 66, No. 25, 2001 8583
isomer, 155 mg, 91%). 1H NMR (CDCl3, 200 MHz) δ 0.91 (3
H, t, J ) 6.7 Hz), δ 0.96 (3 H, d, J ) 7.4 Hz), 1.44-1.72 (3 H,
m), 1.90-2.05 (2 H, m), 2.47 (2 H, t, J ) 7.6 Hz), 4.14 (1 H,
ddd, J ) 11.5 Hz, J ) 5.5 Hz, J ) 2.8 Hz).
) 6.9 Hz), 0.87 (3 H, d, J ) 6.6 Hz), 0.93-1.10 (1 H, m), 1.25-
1.52 (2 H, m), 1.60-1.81 (8 H, m), 1.89-2.01 (2 H, m), 2.27-
2.31 (2 H, m), 4.60-4.69 (2 H, m), 7.20-7.45 (5 H, m); 13C NMR
(CDCl3, 75 MHz): δ 16.1, 20.6, 21.1, 21.9, 23.3, 26.1, 31.1, 34.1,
34.2, 38.2, 40.8, 46.9, 73.8, 73.9, 125.7 (2×), 127.3, 128.3 (2×),
144.5, 173.1; HRMS calcd for C21H32O3: 332.2351. Found:
332.2341.
4-Meth yl-5-p h en yl-5-p en ta n olid e (8b).20 By a procedure
similar to that for 2b (Method E), 4-methyl-5-oxo-5-phenyl-
pentanal (4b, 61 mg, 0.32 mmol) was treated with SmI2/i-PrSH
(0.25 mmol/0.17 mmol) at room temperature to give the title
(1′R,2′S,5′R,5SR)-5-Hyd r oxy-5-tr id eca n oic a cid 2-iso-
p r op yl-5-m eth ylcycloh exyl ester (12e). TLC [EtOAc/hex-
1
compound 8b (cis isomer, 57 mg, 94%). H NMR (CDCl3, 200
ane (20:80)] Rf ) 0.55; IR (neat) 3449, 1734 cm-1 1H NMR
;
MHz) δ 0.76 (3 H, d, J ) 6.1 Hz), 1.68-1.81 (1 H, m), 2.10-
2.31 (2 H, m), 2.67 (2 H, dd, J ) 7.2 Hz, J ) 6.7 Hz), 5.48 (1
H, d, J ) 3.0 Hz), 7.13-7.36 (5 H, m).
(CDCl3, 400 MHz) δ 0.73 (3 H, d, J ) 6.9 Hz), 0.83-1.11 (12
H, m), 1.24-2.11 (25 H, m), 2.29 (2 H, dt, J ) 7.4, 1.9 Hz),
3-Meth yl-5-p h en yl-5-p en ta n olid e (9a ).21 By a procedure
similar to that for 2b (Method E), 3-methyl-5-oxo-5-phenyl-
pentanal (5a , 94 mg, 0.48 mmol) was treated with SmI2/i-PrSH
(0.50 mmol/0.43 mmol) at room temperature to give the title
compound 9a (91 mg, 97%) as a mixture of trans and cis
isomers (77:23). The isomeric ratio changed to trans/cis ) 94:6
when the reaction was conducted at 0 °C. trans-9a : 1H NMR
(CDCl3, 200 MHz) δ 1.09 (3 H, d, J ) 6.2 Hz), 1.82-1.88 (1 H,
m), 2.02-2.31 (3 H, m), 2.68 (1 H, dd, J ) 16.3 Hz, J ) 5.3
Hz), 5.50 (1 H, dd, J ) 7.3 Hz, J ) 4.6 Hz), 7.27-7.36 (5 H,
m). cis-9a : 1H NMR (CDCl3, 400 MHz) δ 1.07 (3 H, d, J ) 6.4
Hz), 1.49-1.56 (1 H, m), 2.12-2.19 (3 H, m), 2.79 (1 H, dd, J
) 11.9, 1.9 Hz), 5.29 (1 H, dd, J ) 12.0, 3.1 Hz), 7.30-7.38 (5
H, m).
3.52-3.59 (1 H, m), 4.66 (1 H, ddd, J ) 10.8, 10.8, 4.3 Hz); 13
C
NMR (CDCl3, 100 MHz): δ 14.1 (CH3), 16.3 (CH3), 20.7 (CH3),
21.1 (CH2), 22.0 (CH3), 22.6 (CH2), 23.4 (CH2), 25.6 (CH2), 26.3
(CH), 29.3 (CH2), 29.6 (CH2), 29.7 (CH2), 31.7 (CH), 31.9 (CH2),
34.3 (CH2), 34.5 (CH2), 36.7 (CH2), 37.5 (CH2), 40.9 (CH2), 47.0
(CH2), 71.4 (CH), 74.1 (CH), 173.3 (C); HR-FAB-MS calcd for
C23H45O3 (M+ + 1): 369.3369. Found: 369.3362.
(2S,2′S,4S,4′S,5R,5′R)-N,N′-Bis(3,4-d im et h yl-2-oxo-5-
p h e n y l-1,3,2-o x a za p h o s p h o la n -2-y l)-e t h a n e -1,2-d i-
a m in e (15).33 According to the known procedure, the chiral
phosphorus(V) reagent 15 was prepared from (1R,2S)-(-)-
ephedrine hydrochloric salt by subsequent treatments with
POCl3/Et3N and ethylenediamine.
Sa len 16. By a procedure similar to that for the related
salen compounds,34 the chiral salen reagent 16 was prepared
by condensation of (1R,2R)-(-)-1,2-cyclohexanediamine with
4-azidomethyl-2-hydroxybenzaldehyde.
(3S,5S)-3-Met h yl-5-h exa n olid e (9b )24 a n d (2R,5S)-2-
Meth yl-5-h exa n olid e (10)25. By a procedure similar to that
for 2b (Method E), a mixture of 3-methyl-5-oxohexanal (5b)
and 2-methyl-5-oxohexanal (6) (1:1, 128 mg, 1.0 mmol) was
treated with SmI2/i-PrSH (0.5 mmol/0.4 mmol) at 0 °C to give
a mixture of (3S,5S)-9b and (2R,5S)-10 (1:1). The analytic
samples were isolated by HPLC with elution of EtOAc/hexane
(1S,2S,5R)-2-Isopr opyl-5-m eth yl-cycloh exan eth iol (17).35
Treatment of (-)-menthol (3.12 g, 20 mmol) with p-toluene-
sulfonyl chloride (7.70 g, 40 mmol) in pyridine (30 mL) at room
temperature for 16 h gave the corresponding tosylate (6.05 g,
97%). The tosylate (2.60 g, 8.4 mmol) was heated (50-60 °C)
with potassium thioacetate (AcSK, 2.80 g, 25 mmol) in Me2-
SO (17 mL) for 36 h. The mixture was cooled and extracted
with CHCl3 (5 × 15 mL). The organic phase was dried (Na2-
SO4), concentrated, and distilled (80 °C, 0.05 mmHg) to give
(1S)-neomenthyl acetate (1.31 g, 73%). Diisobutylaluminum
hydride (DIBAL, 6 mmol, 1 M solution in CH2Cl2) was added
dropwise to a CH2Cl2 solution (20 mL) of (1S)-neomenthyl
acetate (420 mg, 1.96 mmol) at 0 °C. The mixture was stirred
for 5 h and quenched by addition of saturated NH4Cl. Water
(40 mL) and 1 M HCl (20 mL) were added, and the mixture
was extracted with Et2O (4 × 30 mL). The organic phase was
washed with brine, dried (Na2SO4), concentrated, and distilled
(90 °C, 9 mmHg) to give the title compound 17 (330 mg, 98%).
(3:7). (3S,5S)-9b: [R]25 ) -57.7 (c ) 0.1, MeOH); 13C NMR
D
(CDCl3, 125 MHz) δ 21.3, 21.4, 23.7, 36.6, 37.3, 73.6, 172.4.
(2R,5S)-10: [R]25 ) -82.5 (c ) 0.6, CHCl3); 1H NMR (CDCl3,
D
500 MHz) δ 1.20 (3 H, d, J ) 6.8 Hz), 1.34 (3 H, d, J ) 6.2
Hz), 1.49-1.64 (2 H, m), 1.87-1.93 (1 H, m), 2.02-2.10 (1 H,
m), 2.52-2.60 (1 H, m), 4.42-4.47 (1 H, m); 13C NMR (CDCl3,
125 MHz) δ 16.2, 21.1, 25.6, 28.4, 33.0, 74.4, 176.3.
(2S,5R)-2-Meth yl-5-h exa n olid e (10).25 By a procedure
similar to that for 1h (Method B), propanal was condensed
with (S)-1-amino-2-(methoxymethyl)pyrrolidine to give the
corresponding hydrazone. The hydrazone was alkylated with
4-iodo-2-methyl-1-butene, followed by ozonolysis, to give (S)-
2-methyl-5-oxohexanal, [R]26 ) -6.7 (c ) 0.6, CHCl3). By a
D
procedure similar to that for 2b (Method E), (S)-2-methyl-5-
oxohexanal (71 mg, 0.6 mmol) was treated with SmI2/i-PrSH
(0.3 mmol/0.25 mmol) at room temperature to give (2S,5R)-
[R]25 +53.6 (c ) 3.1, CHCl3).
D
(1S,2S,3R,5R)-3-P in a n eth iol (18).37 By a procedure simi-
lar to that for 17, (+)-isopinocampheol was activated as the
mesylate, which was subsequently treated with AcSK and
10 (54 mg, 76%). Solid, mp 40-42 °C; [R]21 ) +63.5 (c ) 0.2,
D
CHCl3).
1-Oxa -2-d eca lon e (11a ).22 By a procedure similar to that
for 2b (Method E), 3-(2-oxocyclohexyl)propanal (7a , 79 mg, 0.51
mmol) was treated with SmI2/i-PrSH (0.25 mmol/0.17 mmol)
at room temperature to give the title compound 11a (trans/
cis ) 96:4, 55 mg, 70%). trans-11a : 1H NMR (CDCl3, 200 MHz)
δ 0.95-2.03 (11 H, m), 2.47-2.61 (2 H, m), 3.82 (1 H, ddd, J
) 10.2 Hz, J ) 10.2 Hz, J ) 4.2 Hz)/4.44 (br dd, J ) 6.7, 3.3
Hz for cis isomer).
DIBAL to give the title compound 18. [R]25 ) -5.7 (c ) 3.7,
D
CHCl3).
(3R)-Ch olesta n eth iol (19).38 A THF solution (5 mL) of 3â-
chloesterol (772 mg, 2.0 mmol) was treated with a mixture of
Ph3P (630 mmol, 2.4 mmol) and diisopropyl diazocarbodiimide
(DIAD, 485 mg, 2.4 mmol) in THF (15 mL) at 0 °C for 2 h to
give the corresponding thioacetate (590 mg, 78%). Reduction
of the thioacetate (138 mg, 0.3 mmol) with LiAlH4 (120 mg,
3.0 mmol) in Et2O (10 mL) for 30 min gave the title compound
19 (122 mg, 99%). Solid, 80-82 °C.
1-Oxa -6-ter t-bu tyl-2-d eca lon e (11b).23 By a procedure
similar to that for 2b (Method E), 3-(2-oxo-5-tert-butylcyclo-
hexyl)propanal (7b, 160 mg, 1.2 mmol) was treated with SmI2/
i-PrSH (0.50 mmol/0.43 mmol) at room temperature to give
the title compound 11b (141 mg, 88%) as a mixture of trans
and cis isomers (81:19). trans-11b: 1H NMR (CDCl3, 300 MHz)
δ 0.84 (9 H, s), 0.82-1.17 (3 H, m), 1.40-1.60 (3 H, m), 1.80-
1.87 (3 H, m), 2.09-2.16 (1 H, m), 2.51-2.69 (2 H, m), 3.80 (1
H, ddd, J ) 10.5 Hz, J ) 10.4 Hz, J ) 4.5 Hz). cis-11b: 1H
NMR (CDCl3, 300 MHz) δ 0.83 (9 H, s), 1.06-1.33 (3 H, m),
1.46-1.61 (4 H, m), 1.81-1.87 (1 H, m), 2.07-2.14 (2 H, m),
2.48 (2 H, t, J ) 7.4 Hz), 4.42 (1 H, d, J ) 2.6 Hz).
(1′R,2′S,5′R,5SR)-5-Hyd r oxy-5-p h en ylp en t a n oic a cid
2-isop r op yl-5-m eth ylcycloh exyl ester (12a ). TLC [EtOAc/
hexane (20:80)] Rf ) 0.26; IR (neat) 3443, 1725 cm-1; 1H NMR
(CDCl3, 300 MHz) δ 0.71 (3 H, d, J ) 6.9 Hz), 0.86 (3 H, d, J
(1S,2R,4R)-(-)-10-Mer ca p toisobon eol (20).39 Treatment
of (1S)-(+)-camphorsulfonic acid (1.16 g, 5 mmol) with SOCl2
gave the corresponding sulfonyl chloride, which was reduced
with LiAlH4 to give the title compound 20 (37% overall yield)
and its endo isomer (7%). 20: Solid, mp 70-72 °C; [R]27
-56.1 (c ) 1.1, CHCl3).
)
D
(S)-(+)-2-(r-Mer ca p t o-r-p h en ylb en zyl)-1-m et h ylp yr -
r olid in e (26).41 According to the known procedure,41 (S)-
proline-N-benzyl carbamate was subjected to a sequence of
esterification, addition with PhMgBr, reduction with LiAlH4
and substitution with Lawesson reagent to give the title
compound 26 in 32% overall yield. [R]25 ) +249.5 (c ) 1.0,
D
CHCl3).